All right. Thanks, Mike. Here are the headlines on the quarter. We beat our Q2 revenue and adjusted EBITDA guidance midpoint. So beat those midpoints. We posted core bookings in excess of core churn, just like we did in Q1. So that's two quarters in a row, and that's the key point for this year, posting quarter after quarter of core bookings in excess of core churn. That's what's going to set us up for our target 3% core organic growth rate in 2025. I'd note that in this year, the core organic growth rate will bounce around a bit based on year-over-year compares it's positive this quarter. But again, the meaningful part of this is putting up core bookings in excess of core churn quarter-by-quarter. Good news also on the adjusted EBITDA front. Q2 adjusted EBITDA, $13.6 million in the second quarter. That is up sequentially from $13.1 million in the first quarter. And as you can see by the midpoint of our guidance, we expect adjusted EBITDA to continue to grow each quarter this year. So again, $13.1 million in Q1, $13.6 million in Q2, $14 million in Q3, $14.9 million in Q4. So the plan is to exit the year at nearly a $60 million adjusted EBITDA run rate. So we're setting up for 2025 with positive core organic growth. We're going to be targeting that 3% number core organic growth next year and continued expansion of adjusted EBITDA to the mid-$60 million next year. So we believe, made the turn, both in terms of starting to show steps towards positive core organic growth and getting past the low point on EBITDA. And now with this quarter and the quarters going forward, bringing EBITDA up each quarter. So again, still in the early stages, but we are starting to see the ship turn here. So we welcomed 155 new customers to Upland in Q2, and that includes 17 new major customers. We also expanded relationships with 275 existing customers, including 41 major expansions. And I will say based on the growth investment that we've made in pipeline generation, SDR capacity, sales capacity, we are starting to see chunkier deals, larger ARR deals for our lead products, and that's a critical kind of green shoot. And so good news that we are starting to see those larger deals where, and it's their marketing-sourced pipeline, right? So the work that we've done on organic search, the work that we've done in terms of accessing intent data, having an SDR capacity to qualify these leads, the product marketing work that we've done, the investment in the sales team that we've done, it's starting to bear some fruit here. Again, I'll caution that it's early, but we're seeing those green shoots including chunkier deals. A few other points. We earned 56 badges in G2's Summer 2024 market reports that was across our portfolio of products. That's up from 44 badges in the spring 2024 reports. Our AI knowledge management solutions, up and right answers in Upland Panveva, continue to garner numerous badges, while Upland Covidien, our AI power proposal management and software, increased earned recognitions another quarter in a row. Additional products to receive badges included Uplanded Genius, which is a computer telephony integration solution, which powers personalized customer service with AI, and Upland Interfax, which is a secure cloud-based fact service and, of course, other products also on the badge list. And again, beginning to see more reviews and more engagement with G2 as a platform, and we expect more goodness to come from there. I would note, Upland Covidien continues to enhance the response and sales proposal process with new regenerative AI model called Covidien AI assist. Covidien is a leader in the RFP and proposal automation industry is dedicated to helping teams easily uncover the right processes and quickly for RFP response generation and quickly create standout proposals and RFP responses. And this beta release of Qvidian AI assist adds these powerful new AI features. And of course, we've also got the partnership with IBM that we've talked about before integrating Watson X AI capabilities in a Qvidian. So these are both examples. When you look at right answers and Panveva, you look at Covidien of where we are doing deep work to integrate AI capabilities into our products. And of course, these were product initiatives that began well over a year ago that are now beginning to come to market, in some cases, in beta, in some cases, generally available. And also note a partner announcement Upland and Ramot is a global leader in cloud-based RIS, PACS radiology solutions for imaging centers and teleradiology providers, announced the milestone transmission of the 40th, 40 million fax through the integration of Ramot PowerServer and Upland Interfax. So it's Interfaces robust security features, including HIPAA compliance and PIA compliance, complement power service, secure HIPAA-compliant architecture. And so we're seeing with our secure file transfer solutions, some great growth characteristics as are also high-margin products and really seeing some success there as we have for some time in health care and financial services, but seeing an acceleration of that, which is great to see. I also a note on Upland Altify. During the quarter, we announced the release 9.12 release, which contained major enhancements to transform the customer experience with Altipy's sales force native products and of course, Altify is a product that really enables B2B enterprise sales forces to coordinate activities, deploy methodology, and a super-efficient way and do the kind of account planning and white space analysis that can really move the needle in terms of sales generation and of course, adding our AI capabilities to that platform. And Altify is sales force native. So the Salesforce partnership has been great for us and at 9.12, again, just the next step in Altify evolution. So a great quarter, another step along the way towards driving growth and driving margin expansion. And with that, I'm going to turn the call over to Mike to review the numbers and guidance. Mike?